OTLK   $6.0  1.18% Market Closed After Close 6.0 0.0

Outlook Therapeutics Inc
Total Cash 32.02M
totalCashPerShare 1.354
EBITDA -61.19M
Total Debt 32.72M
quickRatio 0.753
currentRatio 1.072
Total Revenue
debtToEquity
Revenue/Share
ROA -0.83686996
ROE
grossProfits
freeCashflow -43.59M
operatingCashflow -64.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 153.75M
forwardPE -2.5175097
floatShares 11.92M
sharesOutstanding 23.66M
sharesShort 2.43M
sharesShortPriorMonth 2.32M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.36%
heldPercentInstitutions 0.36%
Short Ratio help_outline 16.63%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue -3.575
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -94.05M
trailingEps -5.89%
forwardEps -2.57%
enterpriseToEbitda -2.51
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.85 3Q 2024
institutionsCount 88
lastUpdated Sept. 16, 2024, 3:03 p.m.